Applied Biological Laboratories

Investment in Series C Preferred Equity

Offering Summary

  1. Biopharma company-SUNY Downstate Medical Center in Brooklyn and Johnson and Johnson Labs NYC.
  2. Committed to the research, development and distribution of natural bioactive molecules for common respiratory illnesses.
  3. A seasoned team of scientists and business leadership.
  4. Applied Biological Laboratories collaborate with some of the leading global academic institutions and world-renowned scientists in cold and flu (Columbia, UCLA, Yale, NYU, Mount Sinai), with special funding from the CDC and NIH—recipient of SBIR

Applied Offering Summary:

Securities Offered: Convertible Preferred Stock.

Price per Preferred share: $50

Conversion Price: $50 per share

Liquidation Preference: Senior to Common Stock.

Voting Rights: Pari Pasu to underlying common Stock.

Subscription Agreement: Applied Biological Subscription Agreement


{{ message }}

{{ 'Comments are closed.' | trans }}

Offering Description

Issuer
Applied Biological Laboratories
Regulation Type
Regulation D 506(c)
Financing Type
Equity
Security Sold
Convertible Preferred Equity
Funding Goal
$10,000,000
Investor Requirement
Accredited Investor Only
Min. Investment
$25,000

Request Information
Issuer's Site Offering Document Invest Now (RegD offering - for accredited investors)
Last updated: 12-29-2021
C2M Securities Investment Banking team is actively working on institutional capital raises and investment opportunities that are not available for general solicitation. If you have an interest in viewing these deals, please reach out to our team by completing the contact form.